Udo Geipel
Impact in
- Infectious Diseases top 10%
- Clostridium difficile and Clostridium perfringens research
- Antimicrobial Resistance in Staphylococcus
-
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Clostridium difficile and Clostridium perfringens research 7
- Antimicrobial Resistance in Staphylococcus 6
-
- Urinary Tract Infections Management 3
- Co-authors
- Klaus Aktories (6 shared papers)Beate Schering (2 shared papers)Martin Herrmann (1 shared paper)M. Bärmann (1 shared paper)Gursharan S. Chhatwal (1 shared paper)Ingo Just (5 shared papers)Walter H. Traub (3 shared papers)Dieter Haas (1 shared paper)
- Journals
- European Journal of Biochemistry (3 papers)Chemotherapy (3 papers)Antibiotics (1 paper)International Journal of Medical Sciences (1 paper)Infection and Immunity (1 paper)
- Partner nations
- Germany
In The Last Decade
Udo Geipel
21 papers receiving 372 citations
Peers
Comparison fields: 5 of 60
- Infectious Diseases 148
- Immunology 141
- Endocrinology 25
- Clinical Biochemistry 30
- Physiology 14
Countries citing papers authored by Udo Geipel
This map shows the geographic impact of Udo Geipel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Geipel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Geipel more than expected).
Fields of papers citing papers by Udo Geipel
This network shows the impact of papers produced by Udo Geipel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Geipel. The network helps show where Udo Geipel may publish in the future.
Co-authors
The 25 scholars most cited alongside Udo Geipel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 105 | |
| 2 | 2009 | 58 | |
| 3 | 2004 | 48 | |
| 4 | 1989 | 44 | |
| 5 | 1990 | 23 | |
| 6 | 1998 | 18 | |
| 7 | [The infected implant: bacteriology]. | 2005 | 17 |
| 8 | 1998 | 16 | |
| 9 | 2021 | 15 | |
| 10 | 1990 | 12 | |
| 11 | 1999 | 7 | |
| 12 | 2009 | 4 | |
| 13 | 1996 | 4 | |
| 14 | 2005 | 3 | |
| 15 | 2020 | 3 | |
| 16 | 2005 | 3 | |
| 17 | 2011 | 2 | |
| 18 | 2011 | 2 | |
| 19 | 2010 | 1 | |
| 20 | Characterization of the ADP-ribosylation of actin by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin. | 1990 | 1 |
About Udo Geipel
Udo Geipel is a scholar working on Infectious Diseases, Epidemiology, Surgery, Neurology and Immunology, having authored 21 papers that have together received 387 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Botulinum Toxin and Related Neurological Disorders (4 papers), Toxin Mechanisms and Immunotoxins (4 papers), Orthopedic Infections and Treatments (4 papers), Surgical site infection prevention (3 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Urinary Tract Infections Management (3 papers). The work is most often cited by research in Infectious Diseases (148 citations), Immunology (141 citations), Endocrinology (25 citations), Clinical Biochemistry (30 citations) and Physiology (14 citations). Udo Geipel has collaborated with scholars based in Germany. Frequent co-authors include Klaus Aktories, Beate Schering, Martin Herrmann, M. Bärmann, Gursharan S. Chhatwal, Ingo Just, Walter H. Traub, Dieter Haas, Mathias Herrmann and Dierk Bauer. Their work appears in journals such as European Journal of Biochemistry, Chemotherapy, Antibiotics, International Journal of Medical Sciences and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.